Cargando…

ODP338 Neuromedin B Receptor Antagonist Suppresses ACTH Secretion and Cell Proliferation in Human and Mouse Corticotroph Adenoma

OBJECTIVE: We previously reported that Neuromedin B (NMB) is expressed in murine pituitary corticotrophs under adrenal insufficiency (1). Because NMB is also expressed in several cancer cells and stimulates ACTH secretion, we hypothesized that NMB is related to corticotroph adenoma cell proliferatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Atsumi, Tatsuya, Sekizaki, Tomonori, Kameda, Hiraku, Nakamura, Akinobu, Miya, Aika, Nomoto, Hiroshi, Yong Cho, Kyu, Motegi, Hiroaki, Miyoshi, Hideaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Neuroendocrinology and Pituitary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625167/ http://dx.doi.org/10.1210/jendso/bvac150.1047

Ejemplares similares

Neuromedin B Receptor Antagonist Suppresses Pomc Expression in AtT-20 Cells and Human Corticotroph Adenoma Cells
por: Sekizaki, Tomonori, et al.
Publicado: (2021)

ODP328 Longitudinal Multidisciplinary Approach for Cabergoline-Resistant Aggressive Prolactinoma Complicated by Multiple Endocrine Neoplasia Type 1
por: Furusawa, Sho, et al.
Publicado: (2022)

ODP332 Maternal Central Diabetes Insipidus Immediately after Delivery, Owing to Vasospasm of the Internal Carotid Artery
por: Yokozeki, Kei, et al.
Publicado: (2022)

ODP285 A Case of Encephalitis and Adrenal Insufficiency in a Patient With Panhypopituitarism After COVID-19 Vaccination
por: Yabe, Ichiro, et al.
Publicado: (2022)

SAT-282 Hypothalamic Pituitary Adrenal Axis Hyperactivity in Db/db Mice
por: Kameda, Hiraku, et al.
Publicado: (2020)

THU044 The Subcellular Localization Of β-Catenin Is Associated With Tumor Size And The Surgical Remission Rate In Growth Hormone-producing Pituitary Adenomas
por: Kuwabara, Saki, et al.
Publicado: (2023)

ODP312 Giant Silent Corticotroph Adenoma: Presentation of 3 Cases
por: Oliveira, Miriam C, et al.
Publicado: (2022)

SAT-LB57 The Spectrum of Genomic and Transcriptomic Alterations in ACTH-Producing and ACTH-Silent Corticotroph Adenomas
por: Lerario, Antonio Marcondes, et al.
Publicado: (2020)

ODP355 The analysis of tumor infiltrative lymphocytes in corticotroph adenomas and its relation to hormonal status
por: Fukuoka, Hidenoi, et al.
Publicado: (2022)

ODP351 Silent Corticotroph Adenomas – Characteristics and Comparisons to Other Non-functioning Pituitary Adenomas: A Case Series
por: Di Ieva, Antonio, et al.
Publicado: (2022)

ODP618 The profile of patients with ACTH-secreting pituitary adenomas and subclinical pituitary apoplexy
por: Tatsi, Christina, et al.
Publicado: (2022)

THU010 A Case Of Cushing(')s Disease Due To T-pit Positive, ACTH Negative Aggressive Corticotroph Pituitary Adenoma
por: Gopinath, Chaitra, et al.
Publicado: (2023)

A Case of Silent Corticotroph Adenoma
por: Ibekwe, Usonwanne U, et al.
Publicado: (2021)

MON-469 Pituitary Corticotroph Lesions: Clinical, Biochemical, and Pathological Characterization of Cushing Disease, Silent Corticotroph Adenomas, and Corticotroph Hyperplasia
por: Castlen, Joseph, et al.
Publicado: (2019)

OR06-03 Serotonin Regulates Corticotroph Tumor Cell Proliferation and ACTH Secretion
por: Zhang, Dongyun, et al.
Publicado: (2020)

ODP301 Corticotroph Macroadenomas with Extensions to Third Ventricle: Four Case Reports
por: Suzuki, Yasuhiro, et al.
Publicado: (2022)

SAT-311 Role of SREBP in Regulation of Corticotroph Tumor ACTH Secretion and Cell Proliferation
por: Zhang, Dongyun, et al.
Publicado: (2020)

LBODP079 A Case of Silent Invasive Corticotroph Adenoma
por: Bendaram, Snigdha Reddy, et al.
Publicado: (2022)

Co Existence of a Corticotroph Adenoma and a Multifunctional Pituitary Cyst
por: McDonnell, David John, et al.
Publicado: (2021)

SAT-271 Block and Replace Therapy Successfully Improved Symptoms in Recurrent Cyclic Cushing’s Disease
por: Kamigaki, Risa, et al.
Publicado: (2020)

ODP339 Nonfunctioning Giant Adenomas
por: Oliveira, Miriam C, et al.
Publicado: (2022)

PMON122 Unveiling the Kraken- An Incidentally Found Silent Corticotroph Adenoma of the Pituitary Gland
por: Shteyman, Sara, et al.
Publicado: (2022)

SAT618 Uncovering The Role Of O-glcnacylation In Pituitary Adenoma Pathogenesis: Insights From Corticotroph Tumors
por: Massman, Logan J, et al.
Publicado: (2023)

MON-309 Prevalence of Silent Corticotroph Adenomas in a Large Cohort of Nonfunctioning Pituitary Adenomas: Plasma Proopiomelanocortin(POMC) Levels and Response to Pasireotide LAR
por: Reyes-Vidal, Carlos, et al.
Publicado: (2020)

PMON129 Pituitary Adenoma Co-Secreting GH, Prolactin and ACTH
por: Wilson, Sarah, et al.
Publicado: (2022)

ODP358 The effect of multi-cultural inter-facility endocrine video case conferencing – A novel model of education during the COVID pandemic
por: Araki, Takako, et al.
Publicado: (2022)

ODP293 Aberant Expression of SF-1 Transcription Factor in ACTH-secreting Pituitary Tumors: Possible Association With Aggressive Disease Evolution
por: Nastase, Valeria, et al.
Publicado: (2022)

ODP311 Giant-versus Macroadenomas: Does Size Really Matter in Pituitary Somatotroph Adenomas?
por: Sendur, Suleyman Nahit, et al.
Publicado: (2022)

Clinical Correlation to E-cadherin and Granulation Patterns in Corticotroph Tumors
por: Lipe, Kristin A, et al.
Publicado: (2021)

Long-Term Corticotroph Function Following Cure of Cushing’s Syndrome
por: Schernthaner-Reiter, Marie Helene, et al.
Publicado: (2021)

SAT-259 Acromegaly by Pituitary Adenoma Associated with ACTH-Independent Cushing Syndrome by Adrenal Carcinoma: Case Report
por: Minuzzi, Ricardo Kunde, et al.
Publicado: (2020)

Potential Role for the RASD1 Glucocorticoid-Responsive Gene in Corticotroph Tumorigenesis
por: Hernández-Ramírez, Laura C, et al.
Publicado: (2021)

THU012 Incidental Pituitary Adenoma In A Patient With Ectopic ACTH Secreting Cushing Syndrome - A Diagnostic Conundrum
por: Nali, Meenakshi Sinduri, et al.
Publicado: (2023)

ODP286 A Case of Synchronous Growth Hormone and Adrenocorticotrophic Hormone Secretion in a Patient with an Incidental Pituitary Adenoma.
por: Maraqa, Sima, et al.
Publicado: (2022)

MON-406 Two Cases of Aggressive Corticotroph Pituitary Tumors Treated with Capecitabine and Temozolomide
por: Tateno, Tae, et al.
Publicado: (2019)

New Transcriptional Insights into Silent and Active Corticotroph Pituitary Tumors at Single Cell Resolution
por: Zhang, Dongyun, et al.
Publicado: (2021)

ODP298 Are there identifiable differences in pituitary adenoma width, extension, invasion, or cystic degeneration in subclinical compared to clinical pituitary apoplexy patients?
por: Heffernan-Marks, Ariella, et al.
Publicado: (2022)

PI3K Inhibition by BKM120 Results in Antiproliferative Effects on Corticotroph Tumor Cells
por: Oliveira, Helen A, et al.
Publicado: (2021)

OR2803 Corticotroph Fate Weighted Cell Differentiation Paradigm For Human Induced Pluripotent Stem Cells
por: Elyse Moore, M, et al.
Publicado: (2023)

Hypercoagulability in ACTH-Dependent Cushing Syndrome
por: Singh Sumal, Amit Kartar, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3otl3fib6455c1q2jjtcguvifa